Melanoma differentiation-associated protein 5 (anti-MDA-5), TIF-1, and NXP-2 cancer (also known as MORC3) are three novel DM-specific autoantibodies that may be useful in predicting the risk of developing cancer [34]. This evidence concerns the gene MORC3 and dermatomyositis.